News
Eli Lilly's obesity drugs delivered 38% revenue growth in the second quarter; but its oral GLP-1 candidate fell short, ...
Three years after President Joe Biden signed the Inflation Reduction Act, the Trump administration has significantly reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback